PitchSend

Omnicell Investor Presentation Deck

Total Year Revenue Composition GAAP ($Million) Connected Devices, Software Licenses, & Other Consumables Technical Services Advanced Services Total Revenue Advanced Services % of Total Revenue Recurring % of Total Revenue Recurring vs Non Recurring Non Recurring Product Recurring Recurring Category Recurring Product Service Service Actual TY-2021 $739 $73 $207 $113 $1,132 10% 35% Year over Year (YoY) Change % 32% -3% 2% 109% 27% Actual TY-2022 $828 $75 $207 $186 $1,296 14% 36% YOY Change % 12% 3% 0% 65% 14% Updated Guidance TY-2023 $705-$715 $222-$227 $208-$213 $1,135-$1,155 18% YOY Change % (Mid-Point) -21% 9% 13% -12% 1. Connected Devices, Software Licenses, and other include, but are not limited to, XT Series automated dispensing systems and products related to Central Pharmacy Dispensing Service and IV Compounding Service. © 2023 Omnicell, Inc. 2. Includes Central Pharmacy Dispensing Service (service portion), IV Compounding Service (service portion), Enliven Health solutions, Specialty Pharmacy Services, 340B solutions, Inventory Optimization Service, and other software solutions.. 14

View entire presentation